Papua New Guinea vs Tunisia: Share of pregnant women with HIV that receive antiretroviral therapy
Papua New Guinea
28.0%
in 2024
Tunisia
32.0%
in 2024
Papua New Guinea rank
78th
Tunisia rank
75th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Papua New Guinea
- Tunisia
How they compare
Tunisia currently reports 32.0% against 28.0% in Papua New Guinea, a difference of 4.0%.
That makes Tunisia's figure about 1.1 times Papua New Guinea's.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Tunisia ahead.
Papua New Guinea ranks 78th and Tunisia ranks 75th of 84 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 1.7% | 1.0% | Tunisia |
| 2010s | 10.9% | 15.5% | 4.6% | Tunisia |
| 2020s | 20.6% | 34.4% | 13.8% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Papua New Guinea or Tunisia?
- Tunisia, at 32.0% against 28.0% in Papua New Guinea as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Papua New Guinea and Tunisia?
- 4.0%, with Tunisia ahead.
- How many years of comparable data are there for Papua New Guinea and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Papua New Guinea and Tunisia rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Papua New Guinea ranks 78th and Tunisia ranks 75th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.